Articles tagged with: Personalized Therapy
News»

The annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) took place earlier this month. The two meetings were attended by tens of thousands of physicians from around the world, and featured a myriad of oral presentations, posters, and e-abstracts summarizing the results of new oncology- and hematology-related research.
Included in the research presented at the two meetings were more than 200 studies discussing new multiple myeloma-related findings.
In addition to the two large meetings held earlier this month, the International Myeloma Working Group (IMWG) …
News»

In a recent review article published in the journal Clinical Cancer Research, two myeloma experts from the Dana-Farber Cancer Institute, Dr. Nikhil Munshi and Dr. Kenneth Anderson, review the latest strategies in the treatment of multiple myeloma.
In their article, the experts discuss newer therapies that appear to be promising in clinical and preclinical studies.
According to the physicians, combination therapies that specifically target a patient’s genetic form of the disease will be required for long-term disease control and ultimately a cure.
Some Historical Perspective
In their review article, Drs. Munshi and …
Opinion»

Ever since I was diagnosed with multiple myeloma five and a half years ago, hardly a day goes by when I don’t read some breathtaking headline about the promise of “personalized medicine” in the treatment of cancer.
News article after news article declares that breakthroughs in unlocking cancer's genetic code will lead to new, highly individualized, highly effective treatments.
Sounds great. How could it not make your heart race a little faster knowing a cure is right around the corner?
Yet, when I go to talk to my doctor, none of this …
News»

Dr. Kenneth Anderson, a world-renowned myeloma specialist, physician and researcher at Dana-Farber Cancer Institute, and Kraft Family Professor at Harvard Medical School, spoke with The Myeloma Beacon about his approach to treating multiple myeloma patients.
This article is the second part of a two-part series based on The Myeloma Beacon’s interview with Dr. Anderson. It will cover Dr. Anderson’s thoughts on where myeloma treatment is headed in the coming years. For more information on Dr. Anderson’s current approach to treating multiple myeloma, please see part one of this series.
Emerging Therapies …